Ultromics receives Breakthrough Device Designation for AI cardiac amyloidosis tool and more digital health briefs

Click Therapeutics has begun a clinical trial for its episode migraine digital therapeutic, and Digital Diagnostics is offering its AI-backed diabetic retinopathy screening at select Labcorp locations.
Source: mobihealthnews - Category: Information Technology Source Type: news